A surrogate endpoint-based provisional approval causal roadmap, illustrated by vaccine development
{{output}}
For many rare diseases with no approved preventive interventions, promising interventions exist. However, it has proven difficult to conduct a pivotal phase 3 trial that could provide direct evidence demonstrating a beneficial effect of the intervention on the... ...
